The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of engineered TCR-T cell therapy (afami-cel, lete-cel) in pediatric synovial sarcoma.
 
Amy Armstrong
Honoraria - Alexion Pharmaceuticals; Alexion Pharmaceuticals
Consulting or Advisory Role - Alexion Pharmaceuticals; SpringWorks Therapeutics
 
Veronique Minard-Colin
Research Funding - Bristol-Myers Squibb/Pfizer (Inst); Roche/Genentech (Inst)
 
John Glod
Research Funding - AdaptImmune (Inst); USWorldMeds (Inst)
 
Samuel John
Patents, Royalties, Other Intellectual Property - UT Southwestern Medical Center, Patent pending on novel anti-LILRB CAR-T cell.
 
Sneha Ramakrishna
No Relationships to Disclose
 
Andrea Ferrari
No Relationships to Disclose
 
Nadège Corradini
No Relationships to Disclose
 
Sandra D'Angelo
Consulting or Advisory Role - AADi; Adaptimmune; GI Innovation; GlaxoSmithKline; Medendi; Nektar; Pfizer; Piper Sandler & Company; Rain Therapeutics; Ratio therapeutics; Replimune; Servier
Research Funding - Amgen; Bristol-Myers Squibb.; Deciphera; EMD Serono; Incyte; Merck; Nektar
Travel, Accommodations, Expenses - Adaptimmune
Other Relationship - Adaptimmune; GlaxoSmithKline; Merck; Nektar
 
Jean-Yves Blay
Leadership - Transgene
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Brian Van Tine
Leadership - Polaris
Honoraria - Beijing Biostar Pharmaceuticals Co., Ltd.; Oncology Education; Total Health Conference
Consulting or Advisory Role - Aadi; Acuta Capital Partners, LLC; Adaptimmune; Advenchen Laboratories; Boxer Capital LLC; Crisper Therapeutics; Daiihi Sankyo; Deciphera; Galapagos NV; Hinge Bio; Kronos Bio, Inc.; Putnam Associates; Salarius Pharmaceuticals, INc.; Syneos Health
Research Funding - Polaris
Patents, Royalties, Other Intellectual Property - Accuronix Therapeutics- Licensing agreement. Sigma-2 Receptor Ligands and Therapeutic uses therefor (006766), • Modular Platform for Targeted Therapeutic Delivery (006755), • Sigma-2 Receptor Ligand Drug Conjugates as Antitumor Compounds, Methods of synth; Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Expert Testimony - Health Advances
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; Kronos Bio, Inc
 
Scott Schuetze
Consulting or Advisory Role - Deciphera
Research Funding - Adaptimmune (Inst); Boehringer Ingelheim (Inst); Rain Therapeutics (Inst); Shanghai Pharma (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Deciphera
 
John Haanen
Stock and Other Ownership Interests - Neogene Therapeutics
Consulting or Advisory Role - Achilles Therapeutics (Inst); AstraZeneca (Inst); bioNTech (Inst); Bristol-Myers Squibb (Inst); CureVac; Eisai (Inst); Immunocore (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Ipsen (Inst); Molecular Partners (Inst); MSD Oncology (Inst); Neogene Therapeutics; Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Sastra Cell Therapy; T-Knife (Inst); Third Rock Ventures; Third Rock Ventures (Inst); TZU
Research Funding - Amgen (Inst); Asher Biotherapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Neon Therapeutics (Inst); Novartis (Inst)
 
Warren Chow
Research Funding - Regeneron
Other Relationship - Advenchen Laboratories; InhibRx
 
Beth Ireland
Employment - Adaptimmune
 
Jane Bai
Employment - US WorldMeds
 
Michael Nathenson
Employment - Adaptimmune; GlaxoSmithKline; US WorldMeds
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson; Merck
Expert Testimony - US DOJ; US DOJ
 
Erin Van Winkle
Employment - US WorldMeds
 
Dennis Williams
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune